Hikma Pharmaceuticals PLC (HIK.L)

GBp 1886.0

(0.91%)

Operating Expenses Summary of Hikma Pharmaceuticals PLC

  • Hikma Pharmaceuticals PLC's latest annual operating expenses in 2023 was 1.04 Billion USD , down -19.57% from previous year.
  • Hikma Pharmaceuticals PLC's latest quarterly operating expenses in 2024 Q2 was 405 Million USD , down 0.0% from previous quarter.
  • Hikma Pharmaceuticals PLC reported a annual operating expenses of 976 Million USD in annual operating expenses 2022, up 36.5% from previous year.
  • Hikma Pharmaceuticals PLC reported a annual operating expenses of 715 Million USD in annual operating expenses 2021, up 15.14% from previous year.
  • Hikma Pharmaceuticals PLC reported a quarterly operating expenses of 588 Million USD for 2023 Q4, down 0.0% from previous quarter.
  • Hikma Pharmaceuticals PLC reported a quarterly operating expenses of 472 Million USD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Hikma Pharmaceuticals PLC (2023 - 2002)

Historical Annual Operating Expenses of Hikma Pharmaceuticals PLC (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 1.04 Billion USD -19.57%
2022 976 Million USD 36.5%
2021 715 Million USD 15.14%
2020 621 Million USD 7.44%
2019 578 Million USD -14.12%
2018 673 Million USD -58.04%
2017 1.6 Billion USD 131.12%
2016 694 Million USD 50.22%
2015 462 Million USD 4.76%
2014 441 Million USD 10.8%
2013 398 Million USD 19.04%
2012 334.34 Million USD 20.82%
2011 276.73 Million USD 24.63%
2010 222.03 Million USD 12.25%
2009 197.79 Million USD 11.98%
2008 176.63 Million USD 36.57%
2007 129.33 Million USD 53.68%
2006 84.16 Million USD 24.51%
2005 67.59 Million USD 46.75%
2004 46.05 Million USD 103.62%
2003 22.62 Million USD 11.51%
2002 20.28 Million USD 0.0%

Peer Operating Expenses Comparison of Hikma Pharmaceuticals PLC

Name Operating Expenses Operating Expenses Difference